
2.73 Delayed Data As of Dec 01 | ![]() Today’s Change | 1.80 Today|||52-Week Range 4.50 | +1.49% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Organogenesis Holdings Inc have a median target of 3.75, with a high estimate of 4.00 and a low estimate of 3.50. The median estimate represents a +37.36% increase from the last price of 2.73.
The current consensus among 2 polled investment analysts is to Buy stock in Organogenesis Holdings Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.